Contact
Positions
Associate Professor
- Organization:
- West Virginia University School of Medicine
- Department:
- Microbiology, Immunology & Cell Biology
- Classification:
- Faculty
Publications
Seman BG, Vance JK, Akers SM, Robinson CM. Neonatal low-density granulocytes internalize and kill bacteria but suppress monocyte function using extracellular DNA. J Cell Science. 2021; 134(5):jcs252528.
Seman BG, Povroznik JM, Vance JK, Rawson TW, Robinson CM. A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis. J Vis. Exp. 2020; 162:e61609.
Seman BG, Vance JK, Rawson TW, Witt MR, Huckaby AB, Povroznik JM, Bradford SD, Barbier M, Robinson CM. Elevated levels of interleukin-27 in early life compromise protective immunity during neonatal sepsis. Infect Immun. 2019; 88(3):e00828-19.
Wirth MD, Robinson CM, Murphy EA, Shivappa N, Hébert JR. The dietary inflammatory index is associated with gastrointestinal infection symptoms in the national health and nutrition examination survey. Int J Food Sci Nutr. 2019 May 20:1-10.
Gleave Parson M, Grimmett J, Vance JK, Witt MR, Seman BG, Rawson TW, Lyda L, Labuda C, Jung JY, Bradford SD, Robinson CM. Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection. Immunol Cell Biol. 2019; 97:445-456.
Bader JE, Enos RT, Velázquez KT, Carson MS, Sougiannis AT, McGuinness OP, Robinson CM, Murphy EA. Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments. Am J Physiol Endocrinol Metab. 2019; 316:E358-E372.
Bader J, Enos R, Velazquez K, Carson M, Nagarkatti M, Nagarkatti P, Chatzistamou I, Davis J, Robinson CM, Murphy EA. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer. Am. J. of Phys-GI and Liver Phys. 2018 314(1):G22-G31.
Jung JY, Gleave Parson M, Kraft JD, Lyda L, Kobe B, Davis C, Robinson J, Peña MMO, Robinson CM. Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner. Immunology 2016 49:35-47.
Cranford TL, Enos RT, Velázquez KT, McClellan JL, Davis JM, Singh UP, Nagarkatti M, Nagarkatti PS, Robinson CM, Murphy EA. Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain. Int J Obes (Lond). 2016; 40:844-51.
Robinson CM, Kobe BN, Schmitt D, Phair B, Gilson T, Jung JY, Roberts L, Liao J, Camerlengo C, Chang B, Davis M, Figurski L, Sindeldecker D, Horzempa J. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections. Bioengineered 2015 6:82-8.
Jung, J-Y, Roberts LL, Robinson CM. The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells. Immunology 2015 144:649-60.
Jung JY, Robinson CM. IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages. Cell Commun Signal. 2014 Mar 11; 12:16.
Roberts LL, Robinson CM. Mycobacterium tuberculosis infection of human dendritic cells decreases integrin expression, adhesion, and migration to chemokines. Immunology. 2014 141:39-51
Jung JY, Madan-Lala R, Georgieva M, Rengarajan J, Sohaskey C D, Bange F-C, Robinson C M. The Intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect. Immun. 2013 81:3198-209.
Jung J-Y, Robinson C M. Interleukin-27 inhibits phagosomal acidification by blocking vacuolar ATPases. Cytokine 2013 62:202-5.
Kraft J D, Horzempa J, Davis C, Jung J-Y, Peña M M O, Robinson, C M. Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses. Immunology 2013 139:484-93.
Research Program
Microbiology, Immunology & Cell Biology
Research Interests
Now accepting applications for a Postdoctoral position.
Research in the laboratory is focused on the involvement of interleukin (IL)-27 in host immune responses to bacterial infections. IL-27 was first identified as a factor that aids in the initiation of T cell responses and interferon-g production. However, since that time a great deal of evidence has also highlighted immune suppressive activity that is ascribed to IL-27 toward a variety of cell types. Our laboratory predominantly investigates IL-27 as a limiting factor in protective responses during infection and vaccination. This theme is integrated into several well-established projects.
The first seeks to understand how IL-27 may contribute to limitations in neonatal and infant immunity. Infections are a major contributor to early life mortality and a number of functional differences have been identified between infant and adult immune cells. We have shown IL-27 to be expressed at an elevated level in neonates and infants as compared with adults. Ongoing studies seek to understand molecular mechanisms that operate to control different levels of IL-27 expression in different age groups. The laboratory is also exploring the consequence of elevated levels of IL-27 in early life immunity with the overarching hypothesis that IL-27 suppresses protective immunity and opposes bacterial clearance during neonatal infection. We have established a neonatal mouse model of gram-negative sepsis in which we explore the influence of IL-27 on infection-related mortality, bacterial clearance, and cell-mediated immune responses.
A second area of research focus involves human macrophage and dendritic cell (DC) responses to infection by Mycobacterium tuberculosis (Mtb). Tuberculosis is a disease that remains a major threat to global public health. The severity of the epidemic has been intensified by the frequency of coinfection with HIV in developing nations and the emergence of multidrug resistant strains. Numerous cytokines have been shown to play important roles regulating adaptive immune responses to Mtb. The long-term objective of this research is to understand the involvement of IL-27 in human macrophage and dendritic cell responses to mycobacteria and the impact of these responses on the complete immune response. This is important during active infection and in the context of vaccination. The underlying hypothesis is that macrophage and DC responses to IL-27 have important implications in controlling bacterial growth as well as in directing the progression and effectiveness of the immune response to Mtb. Human macrophages express, secrete, and respond to IL-27 during infection by Mtb and the live vaccine strain, BCG. Macrophage responses to both bacteria are improved when IL-27 is neutralized. Under these conditions, the proinflammatory response is elevated and the mycobacterial recovery is significantly reduced. Recent studies have examined the macrophage intracellular environment and effector functions. My laboratory has demonstrated that IL-27 negatively regulates lysosomal acidification. IL-27 also blocks recruitment of intracellular molecules that allow for progression of the phagosome to lysosomes. Consequently, neutralization of IL-27 during infection results in increased colocalization of mycobacteria with host lysosomes. Since antigens that are processed through this pathway associate with MHC class II for surface presentation, this has important implications in the induction of adaptive immunity. We are testing this idea using primary human cells and a neonatal mouse model of vaccination and aerosol challenge.
Lastly, in collaboration with other colleagues, we are investigating the impact of opioid exposure during pregnancy on the neonatal immune response. Neonatal abstinence syndrome (NAS) is defined as a postnatal opioid withdrawal condition that develops in neonates when a mother is addicted to, or in some cases, treated with opioids during pregnancy. We are in the midst of an opioid epidemic across the U.S., as well as right here in West Virginia, and there is a major void in understanding is the impact of in utero opioid exposure on immunological responses and subsequent risk of infectious disease sequelae.